Perritt Capital Management’s ProPhase Labs PRPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-15,000
Closed -$60.6K 353
2025
Q1
$60.6K Sell
15,000
-4,000
-21% -$18.4K 0.03% 208
2024
Q4
$144K Buy
19,000
+10,707
+129% +$150K 0.07% 178
2024
Q3
$201K Sell
8,293
-257
-3% -$7.24K 0.1% 154
2024
Q2
$357K Sell
8,550
-20
-0.2% -$1.05K 0.2% 116
2024
Q1
$554K Sell
8,570
-20
-0.2% -$1.01K 0.3% 77
2023
Q4
$388K Sell
8,590
-640
-7% -$29.2K 0.22% 109
2023
Q3
$403K Sell
9,230
-500
-5% -$29.3K 0.23% 108
2023
Q2
$706K Hold
9,730
0.39% 62
2023
Q1
$741K Hold
9,730
0.41% 56
2022
Q4
$937K Sell
9,730
-2,520
-21% -$272K 0.53% 42
2022
Q3
$1.38M Sell
12,250
-2,040
-14% -$237K 0.88% 22
2022
Q2
$1.81M Sell
14,290
-6,550
-31% -$576K 1.1% 16
2022
Q1
$1.46M Sell
20,840
-40
-0.2% -$2.78K 0.79% 20
2021
Q4
$1.5M Buy
20,880
+2,040
+11% +$127K 0.77% 21
2021
Q3
$980K Buy
18,840
+1,050
+6% +$62.5K 0.54% 40
2021
Q2
$1.1M Buy
17,790
+13,273
+294% +$745K 0.58% 38
2021
Q1
$334K Buy
+4,517
New +$433K 0.18% 141

Other funds holding PRPH

Perritt Capital Management's PRPH Position: Q2 2025 in Review

Perritt Capital Management sold out of ProPhase Labs (PRPH) in Q2 2025, closing a stake of 15,000 shares — an estimated $60.6K sold.

Perritt Capital Management first reported a position in PRPH in Q1 2021 and held it in 17 quarters. The position peaked at $1.81M in Q2 2022. 33 funds tracked by Wall St. Rank hold PRPH as of Q2 2025.

  • Perritt Capital Management reported no remaining ProPhase Labs position as of Q2 2025 after selling out during the quarter.
  • Perritt Capital Management sold 15,000 ProPhase Labs shares in Q2 2025, an estimated $60.6K.
  • Perritt Capital Management first reported a position in ProPhase Labs in Q1 2021 and held it in 17 quarters.
  • Perritt Capital Management's ProPhase Labs position peaked at $1.81M in Q2 2022.
  • 33 funds tracked by Wall St. Rank held ProPhase Labs as of Q2 2025.

Based on Perritt Capital Management's 13F filing for Q2 2025, filed 12 Aug 2025.